| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
bluebird bio Inc (NASDAQ: BLUE)
BLUE Technical Analysis
5
| As on 9th Jun 2023 BLUE STOCK Price closed @ 3.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.82 & Strong Sell for SHORT-TERM with Stoploss of 7.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BLUESTOCK Price
| Open | 3.78 | Change | Price | % |
| High | 3.78 | 1 Day | -0.11 | -2.93 |
| Low | 3.62 | 1 Week | 0.30 | 8.96 |
| Close | 3.65 | 1 Month | -0.03 | -0.82 |
| Volume | 2875600 | 1 Year | -7.93 | -68.48 |
| 52 Week High 11.58 | 52 Week Low 2.79 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BLUE Daily Charts |
BLUE Intraday Charts |
Whats New @ Bazaartrend |
BLUE Free Analysis |
|
|
BLUE Important Levels Intraday
| RESISTANCE | 3.96 |
| RESISTANCE | 3.86 |
| RESISTANCE | 3.80 |
| RESISTANCE | 3.74 |
| SUPPORT | 3.56 |
| SUPPORT | 3.50 |
| SUPPORT | 3.44 |
| SUPPORT | 3.34 |
BLUE Forecast April 2024
| 4th UP Forecast | 11.32 |
| 3rd UP Forecast | 8.86 |
| 2nd UP Forecast | 7.34 |
| 1st UP Forecast | 5.82 |
| 1st DOWN Forecast | 1.48 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -1.56 |
| 4th DOWN Forecast | -4.02 |
BLUE Weekly Forecast
| 4th UP Forecast | 6.89 |
| 3rd UP Forecast | 5.85 |
| 2nd UP Forecast | 5.21 |
| 1st UP Forecast | 4.57 |
| 1st DOWN Forecast | 2.73 |
| 2nd DOWN Forecast | 2.09 |
| 3rd DOWN Forecast | 1.45 |
| 4th DOWN Forecast | 0.41 |
BLUE Forecast2024
| 4th UP Forecast | 20.84 |
| 3rd UP Forecast | 15.33 |
| 2nd UP Forecast | 11.92 |
| 1st UP Forecast | 8.51 |
| 1st DOWN Forecast | -1.21 |
| 2nd DOWN Forecast | -4.62 |
| 3rd DOWN Forecast | -8.03 |
| 4th DOWN Forecast | -13.54 |
bluebird bio Inc ( NASDAQ USA Symbol : BLUE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BLUE Business Profile
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; LentiGlobin for the treatment of sickle cell disease; and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's product candidates in oncology include Idecabtagene vicleucel and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has collaboration and license agreements with Bristol-Myers Squibb, Regeneron Pharmaceuticals, Inc., Novartis Pharma AG, Orchard Therapeutics Limited, Medigene AG, Novo Nordisk A/S, Forty Seven, Inc., Gritstone Oncology, Inc., Magenta Therapeutics, Inc., the Seattle Children's Research Institute, University of North Carolina, and the Fred Hutchinson Cancer Research Center. bluebird bio, Inc. has a strategic alliance with National Resilience, Inc. to research, development, and delivery of cell therapies. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Address: 60 Binney Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service